-
公开(公告)号：US20210052670A1
公开(公告)日：2021-02-25
申请号：US17010570
申请日：2020-09-02
Applicant: OXTHERA INTELLECTUAL PROPERTY AB
Inventor： Elisabeth LINDNER , Maria ÅKERMAN , Anna SJÖGREN , Orla MCCALLION
Abstract: The present disclosure is related to pharmaceutical compositions and methods for treating and/or preventing oxalate-related disorders. More particularly, the present disclosure pertains to compositions comprising an oxalate-degrading bacteria Oxalobacter formigenes particularly suitable for the treatment and/or prevention of late stage hyperoxaluria characterized by high plasma-oxalate levels and a progressing decrease in kidney function.
-
公开(公告)号：US20190125807A1
公开(公告)日：2019-05-02
申请号：US16308439
申请日：2017-06-13
Applicant: OXTHERA INTELLECTUAL PROPERTY AB
Inventor： Elisabeth LINDNER , Maria ÅKERMAN , Anna SJÖGREN , Orla MCCALLION
CPC classification number: A61K35/74 , A61K9/4866 , A61K9/4891 , A61P1/00
Abstract: The present disclosure is related to pharmaceutical compositions and methods for treating and/or preventing oxalate-related disorders. More particularly, the present disclosure pertains to compositions comprising an oxalate-degrading bacteria Oxalobacter formigenes particularly suitable for the treatment and/or prevention of late stage hyperoxaluria characterized by high plasma-oxalate levels and a progressing decrease in kidney function.
-
Search Results
2
records
(took 0.022 seconds)
